Bio-reference Labs, Inc. (BRLI) Misses Q1 EPS by 8c (Earlier)
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Price: $4.70 --0%
Financial Fact:
Depreciation and Amortization: 5.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Depreciation and Amortization: 5.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bio-reference Labs, Inc. (NASDAQ: BRLI) reported Q1 EPS of $0.24, $0.08 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $209 million versus the consensus estimate of $216.4 million. Bio-reference Labs, Inc. reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Bio-reference Labs, Inc. (BRLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Bernstein SocGen on Performance Food Group (PFGC): 'Not the quarter we were hoping for, but LT story intact'
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
